Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Editor's Note: PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway.

Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LWK, Chang LS, Li L.

Cancer Res. 2019 Dec 1;79(23):6054. doi: 10.1158/0008-5472.CAN-19-3162. No abstract available.

PMID:
31791961
2.

Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report.

Wu K, Fan J, Liang H, Yao Y, He D.

Medicine (Baltimore). 2019 Nov;98(48):e18000. doi: 10.1097/MD.0000000000018000.

3.

Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.

Guo P, Xing C, Fu X, He D, Dong JT.

J Cell Biochem. 2019 Nov 13. doi: 10.1002/jcb.29443. [Epub ahead of print]

PMID:
31724223
4.

PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: Multicenter validation in patients from the Chinese Prostate Cancer Consortium.

Pei X, Wu K, Sun Y, Gao X, Gou X, Xu J, Gao F, He D, Li L; Chinese Prostate Cancer Consortium.

Urol Oncol. 2020 Jan;38(1):2.e11-2.e17. doi: 10.1016/j.urolonc.2019.07.014. Epub 2019 Oct 28.

PMID:
31672485
5.

Establishment and application of a TaqMan-based one-step real-time RT-PCR for the detection of novel goose-origin astrovirus.

Yin D, Yang J, Tian J, He D, Tang Y, Diao Y.

J Virol Methods. 2020 Jan;275:113757. doi: 10.1016/j.jviromet.2019.113757. Epub 2019 Oct 24.

PMID:
31669331
6.

KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.

Jia J, Zhang HB, Shi Q, Yang C, Ma JB, Jin B, Wang X, He D, Guo P.

Theranostics. 2019 Jul 28;9(19):5464-5477. doi: 10.7150/thno.33282. eCollection 2019.

7.

Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer.

Tang C, Liu T, Wang K, Wang X, Xu S, He D, Zeng J.

Oncol Rep. 2019 Oct;42(4):1307-1318. doi: 10.3892/or.2019.7248. Epub 2019 Jul 25.

8.

BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.

Li F, Yang C, Zhang HB, Ma J, Jia J, Tang X, Zeng J, Chong T, Wang X, He D, Guo P.

Cancer Med. 2019 Aug;8(10):4792-4805. doi: 10.1002/cam4.2385. Epub 2019 Jun 28.

9.

E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.

Li F, Pascal LE, Stolz DB, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani AV, Nelson JB, DeFranco DB, Yoshimura N, Balasubramani GK, Gingrich JR, Maranchie JK, Jacobs BL, Davies BJ, Hrebinko RL, Bigley JD, McBride D, Guo P, He D, Wang Z.

Prostate. 2019 Aug;79(11):1226-1237. doi: 10.1002/pros.23806. Epub 2019 Jun 18.

PMID:
31212363
10.

The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.

Huang J, Lo UG, Wu S, Wang B, Pong RC, Lai CH, Lin H, He D, Hsieh JT, Wu K.

Cell Death Dis. 2019 Jun 4;10(6):437. doi: 10.1038/s41419-019-1669-z.

11.

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.

Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators.

N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31.

PMID:
31150574
12.

A Novel 450 nm Semiconductor Blue Laser System for Application in Colon Endoscopic Surgery: An Ex Vivo Study of Laser-Tissue Interactions.

Xu X, Jiang DL, Liu GX, Wu K, Fan J, Wu D, Li L, Wang X, Guo P, Mu L, Qiao X, He D.

Photobiomodul Photomed Laser Surg. 2019 Jan;37(1):25-30. doi: 10.1089/photob.2018.4531.

PMID:
31050941
13.

Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.

Yun EJ, Lin CJ, Dang A, Hernandez E, Guo J, Chen WM, Allison J, Kim N, Kapur P, Brugarolas J, Wu K, He D, Lai CH, Lin H, Saha D, Baek ST, Chen BPC, Hsieh JT.

Clin Cancer Res. 2019 Jul 15;25(14):4542-4551. doi: 10.1158/1078-0432.CCR-18-3004. Epub 2019 Apr 18.

PMID:
31000589
14.

Development of an attenuated live vaccine candidate of duck Tembusu virus strain.

He D, Zhang X, Chen L, Tang Y, Diao Y.

Vet Microbiol. 2019 Apr;231:218-225. doi: 10.1016/j.vetmic.2019.03.022. Epub 2019 Mar 22.

PMID:
30955813
15.

G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma.

Xu S, Zhang H, Liu T, Chen Y, He D, Li L.

J Cell Physiol. 2019 Nov;234(11):20002-20012. doi: 10.1002/jcp.28597. Epub 2019 Apr 3.

16.

Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation.

Xie H, Liu T, Chen J, Yang Z, Xu S, Fan Y, Zeng J, Chen Y, Ma Z, Gao Y, He D, Li L.

Cancer Lett. 2019 Jul 1;453:193-205. doi: 10.1016/j.canlet.2019.03.044. Epub 2019 Mar 27.

PMID:
30928381
17.

A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China.

He D, Sun Z, Guo J, Zhang Z, Shan Y, Ma L, Li H, Jin J, Huang Y, Xiao J, Wei Q, Ye D.

Asia Pac J Clin Oncol. 2019 Jun;15(3):144-150. doi: 10.1111/ajco.13142. Epub 2019 Mar 15.

18.

Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome.

Fan J, Wu K, Zhang P, He D.

World J Urol. 2019 Dec;37(12):2671-2675. doi: 10.1007/s00345-019-02712-y. Epub 2019 Nov 15.

PMID:
30843089
19.

En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.

Liang H, Yang T, Wu K, He D, Fan J.

World J Urol. 2019 Dec;37(12):2677-2682. doi: 10.1007/s00345-019-02672-3. Epub 2019 Mar 4.

PMID:
30830276
20.

Efficacy of sorafenib adjuvant therapy in northwestern Chinese patients with non-metastatic renal-cell carcinoma after nephrectomy: A multicenter retrospective study.

Wei D, Wu G, Zheng Y, Chen F, Lu J, Wang Y, He D, Wang H, Wang Z, Chen P, Wang Y, Wang Z, Ye Y, Zhu Z, Yuan J.

Medicine (Baltimore). 2019 Feb;98(5):e14237. doi: 10.1097/MD.0000000000014237.

Supplemental Content

Loading ...
Support Center